Pancreatic auto-antibodies have been found to be more prevalent in patients with Crohn’s disease, specifically early-onset Crohn’s disease, ileocolonic disease, and a penetrating phenotype.34,35 The antigenic target has been identified as anti-glycoprotein 2 (anti-GP2).36 This evidence concerns the gene GP2 and Crohn disease.